Skip to Content

Sprix Approval History

FDA Approved: Yes (First approved May 14, 2010)
Brand name: Sprix
Generic name: ketorolac tromethamine
Dosage form: Nasal Spray
Previous Name: ROX-888
Company: Egalet Corporation
Treatment for: Pain

Sprix (ketorolac tromethamine) is an intranasal analgesic for the management of acute moderate to severe pain.

Development History and FDA Approval Process for Sprix

DateArticle
May 17, 2010Approval Roxro Announces FDA Approval of Sprix
Feb  6, 2009Roxro Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide